Molecular imaging techniques are extensively used in non-invasive preclinical and clinical imaging. These molecular imaging methods can provide visualization, characterization and measurement of biological processes taking place at cellular and subcellular levels within living subjects. Positron emission tomography (PET) imaging and single-photon emission computed tomography (SPECT) are the most commonly used molecular imaging techniques. They help in early and accurate diagnosis of various conditions such as cancer, cardiovascular diseases and neurological disorders with the help of targeted molecular probes.
The global Molecular Imaging Market is estimated to be valued at US$ 4786.94 Mn in 2023 and is expected to exhibit a CAGR of 5.4% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
The increasing adoption of non-invasive molecular imaging techniques like PET and SPECT imaging for diagnosis is one of the major trends fueling the market growth. These techniques provide functional and molecular information about various biochemical processes happening inside the body. They help detect diseases at an early stage and further guide targeted treatment with minimum adverse effects. As compared to other invasive diagnostic methods, molecular imaging techniques reduce healthcare costs and improve patient outcomes significantly. Hence, their demand is growing rapidly across various clinical applications like oncology, cardiology and neurology.
Segment Analysis
The global molecular imaging market is segmented by product type, applications, end user and geography. Based on product type, the market is segmented into PET scanners, SPECT scanners, MRI systems, CT scanners, ultrasound systems and optical imaging. PET scanners segment dominates the market and is expected to remain the largest segment during the forecast period. PET scanners provides improved tissue differentiation, quantification of tracer uptake and high sensitivity for specific biomarkers which has increased its adoption in various research and clinical applications.
Key Takeaways
The Global Molecular Imaging Market Size is expected to witness high growth. The market size is projected to reach US$ 7,349.79 Mn by 2030 from US$ 4,786.94 Mn in 2023, growing at a CAGR of 5.4% during 2023-2030.
Regional analysis
North America is expected to dominate the global molecular imaging market during the forecast period. Higher healthcare spending, presence of major industry players in the region and technological advancements are some key factors driving the molecular imaging market in North America. The market in Asia Pacific is expected to witness fastest growth owing to growing geriatric population, rising disposable income and increasing focus of key players on emerging economies in the region.
Key players
Key players operating in the molecular imaging market are GE Healthcare, Bruker Corporation, Fujifilm Holdings Corp., Siemens Healthineers, Koninklijke Philips N.V., Canon Medical Systems Corporation, United Imaging Healthcare Co., Ltd., Mediso Kft., Positron Corporation, Esaote SpA, Carestream Health, Mirada Medical Limited, and Hermes Medical Solutions. GE Healthcare dominates the market owing to its robust product portfolio and strong distribution network globally. Other prominent players are focusing on new product launches and strategic collaborations to strengthen their market presence.
Get more insights on this topic:
https://www.dailyprbulletin.com/molecular-imaging-market-share-analysis/
